165 related articles for article (PubMed ID: 35707728)
1. Iloprost requires the Frizzled-9 receptor to prevent lung cancer.
Sompel K; Dwyer-Nield LD; Smith AJ; Elango A; Backos DS; Zhang B; Gross J; Ternyak K; Matsuda JL; Kopf K; Keith RL; Tennis MA
iScience; 2022 Jun; 25(6):104442. PubMed ID: 35707728
[TBL] [Abstract][Full Text] [Related]
2. Prostacyclin inhibits non-small cell lung cancer growth by a frizzled 9-dependent pathway that is blocked by secreted frizzled-related protein 1.
Tennis MA; Van Scoyk M; Heasley LE; Vandervest K; Weiser-Evans M; Freeman S; Keith RL; Simpson P; Nemenoff RA; Winn RA
Neoplasia; 2010 Mar; 12(3):244-53. PubMed ID: 20234818
[TBL] [Abstract][Full Text] [Related]
3. Prostacyclin reverses the cigarette smoke-induced decrease in pulmonary Frizzled 9 expression through miR-31.
Tennis MA; New ML; McArthur DG; Merrick DT; Dwyer-Nield LD; Keith RL
Sci Rep; 2016 Jun; 6():28519. PubMed ID: 27339092
[TBL] [Abstract][Full Text] [Related]
4. miR-520a-5p regulates Frizzled 9 expression and mediates effects of cigarette smoke and iloprost chemoprevention.
Smith AJ; Do P; Sompel K; Elango A; Tennis MA
Sci Rep; 2022 Feb; 12(1):2388. PubMed ID: 35149732
[TBL] [Abstract][Full Text] [Related]
5. The Second-Generation PGI2 Analogue Treprostinil Fails to Chemoprevent Tumors in a Murine Lung Adenocarcinoma Model.
Dwyer-Nield L; Hickey GA; Friedman M; Choo K; McArthur DG; Tennis MA; New ML; Geraci M; Keith RL
Cancer Prev Res (Phila); 2017 Nov; 10(11):671-679. PubMed ID: 28851689
[TBL] [Abstract][Full Text] [Related]
6. Intranasal Iloprost Prevents Tumors in a Murine Lung Carcinogenesis Model.
Tennis MA; Smith AJ; Dwyer-Nield LD; Keith RL
Cancer Prev Res (Phila); 2022 Jan; 15(1):11-16. PubMed ID: 34556494
[TBL] [Abstract][Full Text] [Related]
7. Prostacyclin and EMT Pathway Markers for Monitoring Response to Lung Cancer Chemoprevention.
New ML; White CM; McGonigle P; McArthur DG; Dwyer-Nield LD; Merrick DT; Keith RL; Tennis MA
Cancer Prev Res (Phila); 2018 Oct; 11(10):643-654. PubMed ID: 30045935
[TBL] [Abstract][Full Text] [Related]
8. Precision Cut Lung Slices as a Preclinical Model for Non-Small Cell Lung Cancer Chemoprevention.
Sompel K; Smith AJ; Hauer C; Elango AP; Clamby ET; Keith RL; Tennis MA
Cancer Prev Res (Phila); 2023 May; 16(5):247-258. PubMed ID: 36888650
[TBL] [Abstract][Full Text] [Related]
9. Loss of Frizzled 9 in Lung Cells Alters Epithelial Phenotype and Promotes Premalignant Lesion Development.
Sompel K; Dwyer-Nield LD; Smith AJ; Elango AP; Vanderlinden LA; Kopf K; Keith RL; Tennis MA
Front Oncol; 2022; 12():815737. PubMed ID: 35924166
[TBL] [Abstract][Full Text] [Related]
10. TARGETING THE PROSTACYCLIN/PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA AXIS IN LUNG CANCER CHEMOPREVENTION.
Geraci MW
Trans Am Clin Climatol Assoc; 2018; 129():48-55. PubMed ID: 30166698
[TBL] [Abstract][Full Text] [Related]
11. Prostacyclin prevents murine lung cancer independent of the membrane receptor by activation of peroxisomal proliferator--activated receptor gamma.
Nemenoff R; Meyer AM; Hudish TM; Mozer AB; Snee A; Narumiya S; Stearman RS; Winn RA; Weiser-Evans M; Geraci MW; Keith RL
Cancer Prev Res (Phila); 2008 Oct; 1(5):349-56. PubMed ID: 19138979
[TBL] [Abstract][Full Text] [Related]
12. Protocol for intranasal chemoprevention delivery in a urethane mouse lung cancer model.
Dwyer-Nield L; Keith RL; Tennis MA
STAR Protoc; 2022 Dec; 3(4):101750. PubMed ID: 36201319
[TBL] [Abstract][Full Text] [Related]
13. Anti-inflammatory effects of the prostacyclin analogue iloprost in an in vitro model of inflamed human dental pulp cells.
Wahyudi R; Seang S; Everts V; Osathanon T; Limjeerajarus CN
Aust Endod J; 2023 Sep; 49 Suppl 1():330-338. PubMed ID: 36723392
[TBL] [Abstract][Full Text] [Related]
14. Iloprost inhibits neutrophil-induced lung injury and neutrophil adherence to endothelial monolayers.
Riva CM; Morganroth ML; Ljungman AG; Schoeneich SO; Marks RM; Todd RF; Ward PA; Boxer LA
Am J Respir Cell Mol Biol; 1990 Oct; 3(4):301-9. PubMed ID: 1698399
[TBL] [Abstract][Full Text] [Related]
15. Peroxisome proliferator-activated receptor alpha is crucial for iloprost-induced in vivo angiogenesis and vascular endothelial growth factor upregulation.
Biscetti F; Gaetani E; Flex A; Straface G; Pecorini G; Angelini F; Stigliano E; Aprahamian T; Smith RC; Castellot JJ; Pola R
J Vasc Res; 2009; 46(2):103-8. PubMed ID: 18617751
[TBL] [Abstract][Full Text] [Related]
16. Cancer chemoprevention through Frizzled receptors and EMT.
Sompel K; Elango A; Smith AJ; Tennis MA
Discov Oncol; 2021; 12(1):32. PubMed ID: 34604862
[TBL] [Abstract][Full Text] [Related]
17. Endobronchial miRNAs as biomarkers in lung cancer chemoprevention.
Mascaux C; Feser WJ; Lewis MT; Barón AE; Coldren CD; Merrick DT; Kennedy TC; Eckelberger JI; Rozeboom LM; Franklin WA; Minna JD; Bunn PA; Miller YE; Keith RL; Hirsch FR
Cancer Prev Res (Phila); 2013 Feb; 6(2):100-8. PubMed ID: 23268837
[TBL] [Abstract][Full Text] [Related]
18. Phase Ib trial of inhaled iloprost for the prevention of lung cancer with predictive and response biomarker assessment.
Miller YE; Ghosh M; Merrick DT; Kubala B; Szabo E; Bengtson L; Kocherginsky M; Helenowski IB; Benante K; Schering T; Kim J; Kim H; Ha D; Bergan RC; Khan SA; Keith RL
Front Oncol; 2023; 13():1204726. PubMed ID: 37711198
[TBL] [Abstract][Full Text] [Related]
19. Iloprost, a prostacyclin analog, inhibits the invasion of ovarian cancer cells by downregulating matrix metallopeptidase-2 (MMP-2) through the IP-dependent pathway.
Ahn JH; Lee KT; Choi YS; Choi JH
Prostaglandins Other Lipid Mediat; 2018 Jan; 134():47-56. PubMed ID: 29292033
[TBL] [Abstract][Full Text] [Related]
20. A prostacyclin analogue, iloprost, protects from bleomycin-induced pulmonary fibrosis in mice.
Zhu Y; Liu Y; Zhou W; Xiang R; Jiang L; Huang K; Xiao Y; Guo Z; Gao J
Respir Res; 2010 Mar; 11(1):34. PubMed ID: 20302663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
